VISN-wide BPA for point of care whole blood glucose testing equipment and supplies
Ended Awarded Last action
- Contract number
- 36C25623N0137
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 16
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $40,362
Award facts
- Contract value 100% obligated
- $40,362.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$20,837 | |
| Original award | $61,200 |
About this award
Roche Diagnostics Corporation has been awarded a call under a Veterans Integrated Service Network 16 (VISN-16) Blanket Purchase Agreement for point-of-care whole blood glucose testing equipment and supplies. This contract, awarded on October 1, 2022, carries a ceiling value of $40,362.48 under a firm fixed-price arrangement and operates under the In Vitro Diagnostics, Reagents, Test (FSS-65-VII) General Services Administration Schedule. The contract was performed at the vendor's Castleton, Indiana facility and has an ultimate completion date of September 30, 2023. This award does not contain a set-aside designation and represents an open competition award.
This BPA call is one component of Roche Diagnostics' extensive federal contracting portfolio across the Department of Veterans Affairs and other federal healthcare entities. The company maintains multiple active indefinite delivery vehicles and blanket purchase agreements with various VISNs and the Defense Health Agency, with contract values ranging substantially and extending through 2030. Roche Diagnostics' federal offerings encompass a comprehensive range of diagnostic capabilities, including molecular diagnostics, clinical chemistry analysis, immunochemistry testing, and point-of-care testing devices, positioning the company as a primary supplier of advanced diagnostic solutions to military, veterans, and civilian healthcare systems.
Quick answers
Who was awarded contract 36C25623N0137?
36C25623N0137 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 16 (Veterans Health Administration) on October 1, 2022.
How much is contract 36C25623N0137 worth?
The government has obligated $40,362 on 36C25623N0137.
Is contract 36C25623N0137 an order under another contract?
Yes. 36C25623N0137 is a BPA call under V797P5279B-36C25621A0023, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25623N0137 competed?
The extent of competition for 36C25623N0137 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award